Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone acetate + lidocaine injection at GB-20 versus duloxetine for fibromyalgia pain
IRCT20210308050630N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylprednisolone, lidocaine and duloxetine in fibromyalgia (FM) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Body pain. Started Mar 2021; status: completed.
02
Drugs
methylprednisolonelidocaineduloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT20210308050630N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210308050630N1.